All Insiders Activity for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)
|
|
|
|
|
|
|
| Date |
Name: |
Shares |
Transaction |
Value
|
|
|
07/12/19
|
Sandesh Seth,
Director, Chairman & CEO
|
1,500,000
|
Acqusition
at $0.232 per share.
|
$348,000
|
|
07/12/19
|
Richard I. Steinhart,
|
250,000
|
Acqusition
at $0.232 per share.
|
$58,000
|
|
07/12/19
|
Dale L. Ludwig,
Chief Scientific Officer
|
400,000
|
Acqusition
at $0.232 per share.
|
$92,800
|
|
07/12/19
|
Steven O'Loughlin,
Principal Financial Officer
|
400,000
|
Acqusition
at $0.232 per share.
|
$92,800
|
|
07/12/19
|
Mark S. Berger,
Chief Medical Officer
|
400,000
|
Acqusition
at $0.232 per share.
|
$92,800
|
|
07/12/19
|
Jeffrey W. Chell,
|
250,000
|
Acqusition
at $0.232 per share.
|
$58,000
|
|
07/12/19
|
Anil Kapur,
Chief Commercial Officer
|
400,000
|
Acqusition
at $0.232 per share.
|
$92,800
|
|
07/12/19
|
Ajit S. Shetty,
|
250,000
|
Acqusition
at $0.232 per share.
|
$58,000
|
|
07/12/19
|
C. David Nicholson,
|
250,000
|
Acqusition
at $0.232 per share.
|
$58,000
|
|
03/05/19
|
Mark S. Berger,
Chief Medical Officer
|
3,500
|
Option Exercise
at $0.60 per share.
|
$2,100
|
|
02/21/19
|
Sandesh Seth,
Director, Chairman & CEO
|
8,125
|
Option Exercise
at $0.60 per share.
|
$4,875
|
|
12/10/18
|
Sandesh Seth,
Director, Chairman & CEO
|
10,000
|
Buy
at $0.4372 per share.
|
$4,372
|
|
12/10/18
|
Steven O'Loughlin,
Principal Financial Officer
|
10,000
|
Buy
at $0.435 per share.
|
$4,350
|
|
11/19/18
|
Dale L. Ludwig,
Chief Scientific Officer
|
10,000
|
Buy
at $0.4499 per share.
|
$4,499
|
|
07/17/18
|
Sandesh Seth,
Director, Chairman & CEO
|
10,000
|
Buy
at $0.79 per share.
|
$7,900
|
|
|
|
|
|
|
|
|